• S1E2 - Ophthalmology Morning Commute: New Clinical Approaches and Sequencing of Age-Related Macular Degeneration Treatments

  • 2024/01/12
  • 再生時間: 22 分
  • ポッドキャスト

S1E2 - Ophthalmology Morning Commute: New Clinical Approaches and Sequencing of Age-Related Macular Degeneration Treatments

  • サマリー

  • In this episode, our faculty take a deeper dive into their discussion of treatments of neovascular AMD, including anti-VEGF agents and some of the newer agents, including a bispecific antibody that inhibits both VEGF and Ang2.

    Visit www.morningcommutepodcast.com/AMD2 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit

    続きを読む 一部表示

あらすじ・解説

In this episode, our faculty take a deeper dive into their discussion of treatments of neovascular AMD, including anti-VEGF agents and some of the newer agents, including a bispecific antibody that inhibits both VEGF and Ang2.

Visit www.morningcommutepodcast.com/AMD2 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit

S1E2 - Ophthalmology Morning Commute: New Clinical Approaches and Sequencing of Age-Related Macular Degeneration Treatmentsに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。